Introduction
AKT2 and the closely related AKT1 are human cellular homologs of the viral oncogene v-akt (Staal, 1987) . The AKT2 oncogene has been shown to be ampli®ed and/or overexpressed in human ovarian and pancreatic carcinomas (Cheng et al., 1992; Ruggeri et al., 1998) . In normal adult mice, expression of Akt2 mRNA and Akt2 protein is ubiquitous, with highest levels in skeletal muscle (Altomare et al., 1995) . In situ hybridization of mouse embryos indicates that Akt2 is expressed more abundantly than Akt (the murine homologue of human ATK1) in muscle, liver and especially brown fat, tissues which are highly insulinresponsive and actively involved in glucose metabolism (Altomare et al., 1998) .
The AKT2 protein (also known as protein kinase Bb, PKBb) is a serine/threonine kinase related to protein kinases A and C (Jones et al., 1991; Cheng et al., 1992) . The amino terminus of AKT2 contains a pleckstrin homology (PH) domain, a region shared by many molecules involved in signal transduction. Like AKT1, the AKT2 kinase is activated in response to a wide variety of growth factors or insulin through phosphatidylinositol 3-kinase (PI3K) . Ras can also activate AKT2 presumably via direct interaction with the PI3K catalytic subunit, p110a . AKT2 and other members of the AKT/PKB family are activated by 3-phosphoinositide-dependent protein kinase-1 in the presence of the PI3K products phosphatidylinositol 3,4,5-trisphosphate (PtdIns(3,4,5)P3) and phosphatidylinositol 3,4-bisphosphate (PtdIns(3,4)P2) (Walker et al., 1998) . Furthermore, integrin-linked kinase regulates AKT1 activity in a PI3K-dependent manner (Delcommenne et al., 1998) .
Recent studies have linked AKT1 to such diverse processes as inhibition of apoptosis, by phosphorylating BAD and caspase-9 (Datta et al., 1997; del Peso et al., 1997; Blume-Jensen et al., 1998) , and insulin metabolism, by regulating intracellular tracking of vesicles containing glucose transporter 4 (GLUT4) (Cong et al., 1997) . The elevated expression of AKT2 in brown fat and other tissues prominently involved in glucose metabolism (Altomare et al., 1998) suggested that AKT2 may mediate some of the eects of insulin by in¯uencing glucose uptake via membrane translocation of GLUT4. Indeed, recently AKT2 has been observed in Glut4-containing vesicles (Calera et al., 1998) . Moreover, both AKT1 and AKT2 inactivate glycogen synthase kinase-3 (GSK3), suggesting a potentially important role of AKT family members in glycogen synthesis (Cross et al., 1995; Mitsuuchi et al., 1998) .
Despite the fact that AKT2 and AKT1 share certain downstream targets these kinases appear to dier with regard to their involvement in human cancer. Unlike AKT2, alterations of AKT1 are rarely reported in human cancers, and AKT2, but not AKT1, has been shown to be oncogenic when experimentally overexpressed in mammalian cells (Cheng et al., 1997) . We performed yeast two-hybrid screening, using human AKT2 as bait, and have identi®ed a novel protein containing multiple signaling motifs. This AKT2 partner, designated APPL, is an adaptor protein that may tether inactive AKT2 to p110a in the cytoplasm.
Results

Identi®cation of AKT2 interactors
Thirty-one positive clones were identi®ed from 5610 6 primary yeast transformants by sequential yeast growth and color selections, as described in Materials and methods. Restriction enzyme mapping analysis demonstrated that these clones belonged to two distinct groups. A clone (aip1-c) containing the longest insert was chosen from the more abundant group (26 of 31 clones) and characterized in detail. The 1.6-kb insert cDNA of aip-1-c, encoding a putative AKT2 interaction site, contains a translational stop codon followed by 835-bp of 3'-untranslated sequence. To assess the expression of this AKT2-interactor in mammalian cells, antisera were raised against GST-fused aip1-c protein (GSTaip1-c) in rabbits. Antisera were characterized as described in Materials and methods, and an antiaip1-c antiserum was chosen and used in studies described here. The anti-aip1-c antiserum speci®cally detected an 83-kDa protein in A2780 cells ( Figure 1a , lane 1) and a variety of other cell lines (i.e., NIH3T3, Rat-1, PANC-1) that were tested (data not shown).
cDNA cloning of an AKT2 interactor
Altogether, 5.97 kb of contiguous DNA was sequenced from four overlapping clones, isolated by library screening, and a 5'-RACE product. Nucleotide sequence analysis revealed a 57-bp 5' untranslated sequence, an open reading frame (709 amino acids, Figure 1b) , and 3786-bp of 3'-untranslated sequence. The predicted protein has a relative molecular mass of 80 kDa and a pI of 5.18. Although an in-frame stop codon is not present in the 57-bp 5'-untranslated sequence, an AUG codon is located in a context (UCCGCCACGAUGC) that is similar to the consensus sequence of translation initiation described by Kozak (1987) . To assess this putative translation initiation site, a cDNA encoding the predicted open reading frame with an HA epitope tagging sequence at its amino terminus was cloned into the expression vector pcDNA3. Transfection experiments demonstrated that the protein immunoprecipitated with anti-HA antibody was only slightly larger than the endogenously expressed protein recognized by the anti-aip1-c antiserum ( Figure 1a , lane 2), suggesting that the 5.97 kb cDNA includes the entire coding region of the AKT2-interacting protein. Immunoprecipitates of anti-aip1-c antiserum contain both the endogenous p83-kDa and HA-tagged proteins, indicating that the anti-aip1-c antiserum immunoprecipitates both the endogenously and exogenously expressed AKT2-interactor ( Figure 1a, lane 3) .
The AKT2 interactor, APPL, has features of a signaling molecule Analysis of the predicted protein sequence suggested that this AKT2-interactor contains a PH, PTB, and leucine zipper domains and that the protein is highly hydrophilic with no obvious intervening transmembrane domain (Figure 2a,c) . Each of these regions has been observed in many signal transduction proteins as a functional interaction domain with speci®c targets. We therefore designated this protein APPL (Adaptor protein containing PH domain, PTB domain and Leucine zipper motif).
APPL encodes predicted coiled-coil structures at its amino and carboxyl terminus (Figure 2a,b) . The ®rst stretch of the a-helical coiled-coil structure consists of four heptad repeats (the amino acids within each repeat are designated a-g in Figure 2d ). In this helix, the leucine or isoleucine stretch at the d-position and the hydrophobic amino acid stretch at the a-position are consistent with that of a highly conserved leucine zipper motif. The fourth coiled-coil structure, found at the carboxyl terminus of APPL, has the high probability score and hydrophilicity (Figure 2b,c) . Secondary structure and coiled-coil structure predic- tions indicate that this carboxyl region contains a single helical bundle similar to those reported for centromeric protein E (Yen et al., 1992; Thrower et al., 1995) , membrane-organizing extension spike protein (Lankes et al., 1993) , and troponin T (Bullard et al., 1998) (data not shown). The PH domain consists of approximately 100 amino acids, a typical size for such domains. A similarity search revealed that this sequence is similar to the PH domains of oligophrenin-1 and Graf, two members of the GTPase-activating protein (GAP) family (Figure 3a ) (Hildebrand et al., 1996; Billuart et al., 1998) . The PTB domain of APPL shares 47% similarity with the PTB domains of both CED-6, an adaptor protein that promotes engulfment of apoptotic cells in C. elegans (Liu and Hengartner, 1998) , and IB1, a GLUT2 gene transactivator (Bonny et al., 1998) (Figure 3b) . Moreover, the PTB domain of the adaptor protein Shc has been reported to contain two anti-parallel b sheets and three a helices , and secondary structure prediction programs suggest that the PTB domain of APPL also conserves these structural elements (Figure 3b ).
AKT2 interacts with APPL PTB domain
To characterize the interaction between AKT2 and APPL, combinations of truncated forms of AKT2 (i.e., PH domain or catalytic domain) and APPL (PTB domain or carboxy-terminal coiled-coil domain) proteins were tested for interactions by two-hybrid system. As shown in Table 1 , these assays demonstrated that the physical interaction sites reside in the catalytic domain of AKT2 and the PTB domain of APPL.
APPL expression in tissues
Northern blot analysis revealed two major APPL transcripts of approximately 7.0 and 4.6 kb in all tissues examined, whereas ®ve APPL-hybridizing transcripts (7.0, 6.0, 4.6, 3.5 and 2.8 kb) were identi®ed in heart and skeletal muscle (Figure 4) . We con®rmed that the APPL cDNA we cloned corresponds to the 7.0-kb transcript by probing the same membrane sequentially with several independent portions of the APPL cDNA (data not shown). APPL transcripts were most abundant in skeletal muscle, heart, ovary and pancreas, all organs expressing abundant levels of AKT2 mRNA (Cheng et al., 1992; Altomare et al., 1995 Altomare et al., , 1998 Ruggeri et al., 1998) .
Interaction of APPL and AKT2 in mammalian cells
To verify a direct interaction of APPL with AKT2 in vivo, co-immunoprecipitation and subsequent Western blot analyses were performed by using various Akt antibodies and anti-aip1-c (APPL) antiserum, respectively. As shown in Figure 5a , Western blot analysis with anti-aip1-c antiserum revealed that APPL is coimmunoprecipitated with AKT2 and, to a lesser extent, AKT1 and AKT3. Furthermore, we reversed the coimmunoprecipitation procedure. HA-Akt1 or HA-AKT2 was transfected into A2780 cells, and coimmunoprecipitation with anti-aip1-c antiserum followed by Western blot analysis with anti-HA antibody was performed. As shown in Figure 5b , HA-Akt1 or HA-AKT2 expressed in cells co-immunoprecipitated with APPL.
AKT2 is activated by growth factors through PI3K, and APPL has a potential tyrosine-phosphorylation site (41Y) known to be recognized by the SH2 domain of the PI3K regulatory subunit p85, we tested if APPL binds to PI3K. Other possible partners identi®ed through sequence analysis of APPL include the adaptor protein Grb2 and Shc (Figure 1b) . Coimmunoprecipitation experiments demonstrated that APPL readily co-immunoprecipitates with p110a, but only slightly with p85, Shc, or Grb2 (Figure 5a) . Since the expression level of AKT1 is somewhat higher than (a) Schematic structure of leucine zipper motif, coiled-coil structure, PH domain, and PTB domain of APPL. Scale represents number of amino acid residues (a.a.). Bar indicates the region of aip1-c. (b) Probability of coiled-coil structure plotted against residue number. High scores were observed in both amino-terminal and carboxy-terminal regions, residues 235 ± 255 and 628 ± 666, respectively. (c) Hydrophilicity pro®le of APPL. Hydropathic pro®le of the conceptual APPL protein was analysed and plotted against the residue number by using the Kyte and Doolittle algorithm included in the GCG program. (d) Schematic representation of APPL leucine zipper, depicting hypothetical ahelical structure and locations of leucine or isoleucine residues (*), as determined using GCG Helicalwheel program. Hydrophobic amino acids are boxed that of AKT2 in A2780 cells (data not shown), these data suggest that APPL preferentially binds to AKT2 and may act as an adaptor protein between PI3K and AKT2.
The AKT2-APPL interaction depends on AKT2 activation status
We previously showed that AKT2 localizes in the cytoplasm and translocates to the plasma membrane upon stimulation by insulin , presumably due to binding of the PH domain of AKT2 to PI3K products. To determine if APPL translocates to the plasma membrane with AKT2, green¯uorescence protein (GFP)-APPL or GFP-AKT2 was expressed in A2780 cells. As shown in Figure 6a , like AKT2, APPL localizes primarily in cytoplasm. Following insulin stimulation, recruitment of GFP-AKT2 to the cell membrane was observed in 70% of transfected cells, whereas GFP-APPL did not translocate under these conditions (Figure 6a ), suggesting that AKT2 does not co-localize with APPL when AKT2 is active.
To characterize the interaction between AKT2 and APPL, we performed in vitro protein interaction analyses by a GST pull-down assay. GST-APPL(PTB) or GST itself were puri®ed from E. coli (Figure 6b ) and incubated with lysates prepared from insulin-stimulated or unstimulated A2780 cells. Kinase assays demonstrated that, following insulin stimulation, AKT2 is phosphorylated and activated, as indicated by the slower migration of the active form of AKT2 (upper band in Figure 6c increased amount of active AKT2 and decreased amount of inactive AKT2 was observed in insulinstimulated cells. As indicated in Figure 6c (upper and lower panels), the GST-APPL(PTB) protein pulls down only the inactive form of AKT2. The amount of inactive AKT2 pulled down by GST-APPL(PTB) protein was consistently decreased following insulin stimulation (Figure 6c, lanes 3 and 4) . GST protein alone does not pull down AKT2 (Figure 6c , lanes 5 and 6). These data suggest that AKT2 binds to APPL in the cytoplasm when it is inactive, and must be released from APPL in order to be activated.
Fluorescence in situ hybridization (FISH) mapping
FISH analysis was performed with a bacterial arti®cial chromosome (BAC) containing the entire coding region of APPL. Twenty metaphases with¯uorescent signals hybridized to the short arm of chromosome 3 were examined. All¯uorescent signals on chromosome 3 were located at p21.1 or at the boundary between p14 and p21, i.e. 3p14.3-21.1 (Figure 7) .
Discussion
Previous studies have identi®ed several AKT1 interactors as substrates including BAD and caspase-9 (Datta et al., 1997; Blume-Jensen et al., 1998) which are important in cell survival, and GSK3, which is crucial to glycogen synthesis (Cross et al., 1995) . AKT2 has also been shown to phosphorylate and inactivate GSK3 , suggesting a central role of Akt family members in insulin-mediated signaling. Upstream regulators of AKT1 include 3-phosphoinositide-dependent protein kinase-1 and integrin-linked kinase (Walker et al., 1998; Delcommenne et al., 1998) . APPL represents the ®rst adaptor molecule shown to interact with members of the Akt family. Yeast two-hybrid screening, in vitro protein interaction analyses, and co-immunoprecipitation experiments strongly support a speci®c interation between AKT2 and APPL. Moreover, Northern blot analyses demonstrated elevated levels of APPL mRNA in tissues such as ovary, pancreas and skeletal muscle, in which AKT2 mRNA is also abundant. APPL appears to bind preferentially to AKT2, suggesting that this adaptor may facilitate future studies that may dierentiate the physiological and oncogenic activities of AKT2 from those of AKT1.
By using various GST-fusion recombinants of APPL as substrates in protein kinase assays, we con®rmed that AKT2 does not phosphorylate APPL in vitro (data not shown). Indeed, the deduced amino acid sequence of APPL does not contain the consensus sequence R- + RNA from various tissues were hybridized to radiolabeled APPL cDNA probe (upper panel). Lane number, tissue: 1, heart; 2, brain; 3, placenta; 4, lung; 5, liver; 6, skeletal muscle; 7, kidney; 8, pancreas; 9, spleen; 10, thymus; 11, prostate; 12, testis; 13, ovary; 14, small intestine; 15, colon; 16, peripheral blood. Hybridization of the same blot to GAPDH probe (lower panel). Molecular weight markers are depicted in kb In left panel, cell lysates were subjected to SDS ± PAGE, and expression of HA-Akt1 or HA-AKT2 was con®rmed by Western analysis using anti-HA antibody. In right panel, co-immunoprecipitation and subsequent Western analysis were performed using anti-aip1-c (APPL) antiserum and anti-HA antibody, respectively X-R-X-X-S/T (where R refers to Arg, X signi®es any amino acid, and S and T represent Ser and Thr, respectively) required for phosphorylation by AKT1 (Datta et al., 1997; del Peso et al., 1997) . Thus, APPL does not appear to be a direct phosphorylation target of AKT2.
Proteins involved in signal transduction often contain regulatory modules such as PH, Src homology 2, and PTB domains Pawson, 1995) . Such units can determine the subcellular localization of a protein by mediating protein/protein or protein/lipid interactions (Harlan et al., 1994; Rameh et al., 1995; Zhou et al., 1995) . APPL appears to be an adaptor protein that contains multiple regulatory motifs, including a PH domain. Some PH domains, such as those of AKT1 (Franke et al., 1997) , bind with relatively high anity to the PI3K products PtdIns(3,4)P2 and PtdIns(3,4,5)P3. These phospholipids are nominally absent in quiescent cells and only appear in response to cell stimulation as products of PI3K (Carpenter and Cantley, 1996) and, therefore, could provide a mechanism for regulated recruitment of proteins to the membrane. It is generally believed that translocation of AKT1 or AKT2 to the membrane is required for full activation. While we cannot rule out the possibility that APPL is recruited to the plasma membrane immediately following mitogenic stimulation, we did not observe such translocation under the conditions tested in this study. Our data indicate that APPL interacts with inactivated AKT2 as well as with Figure 6 Translocation and protein interaction. (a) GFP-APPL and GFP-AKT2 expression plasmid was transfected into A2780 cells on poly-D-lysine-coated microscope slides. Cells were serum-starved for 24 h and treated for 10 min with (+) or without (7) 100 nM insulin, followed by ®xation in 3.5% paraformaldehyde. (b) GST-APPL(PTB) and GST proteins were puri®ed from BL21 and veri®ed by SDS ± PAGE with Coomassie brilliant blue (CBB) staining. (c) GST pull-down and protein kinase assays. A2780 cells were serum-starved for 24 h prior to insulin stimulation (100 nM for 10 min), and lysates prepared from stimulated (+) or unstimulated (7) cells were incubated with each GST recombinant or anti-KT2 antibody. Precipitates were washed with lysis buer and subjected to SDS ± PAGE followed by Western blot analysis with anti-AKT2 antibody, or by in vitro protein kinase assay using histone H2B as substrate p110a. APPL may function as an adaptor that tethers inactive AKT2 to p110a in the cytoplasm and, thereby, may expedite recruitment of these molecules to the cell membrane upon mitogenic stimulation.
Our data also indicate that the APPL-AKT2 interaction occurs between the PTB domain of APPL and the catalytic domain of AKT2. The PTB domain of Shc recognizes phosphorylated tyrosine residues within the consensus sequence fNPXphosphoY (where f signi®es a hydrophobic amino acid, X refers to any amino acid, and N, P, and Y represent Asn, Pro, and Tyr, respectively) (Kavanaugh et al., 1995; Zhou et al., 1995) . However, AKT2 does not possess this consensus sequence, suggesting that the APPL(PTB)-AKT2 interaction diers from that occurring between the PTB domain of Shc and its target proteins. The PTB domain of APPL shows a high degree of homology with PTB domains found in CED-6 and IB1. CED-6 is an adaptor that acts in a signal transduction pathway mediating recognition and engulfment of apoptotic cells in C. elegans. IB1 is a JIP-1-related protein which binds to GTII, a cis-regulatory element of the GLUT2 promoter, and transactivates the GLUT2 gene. Therefore, should APPL prove to be a regulator of AKT2 signaling, it could represent an important target for the treatment of disease entities, such as cancer, in which AKT2 has been implicated in their pathology.
Finally, the localization of APPL, to the 3p14.3-21.1 chromosomal region is intriguing. Deletions and other rearrangements of this region have been reported in a variety of tumor types, including malignant mesotheliomas and carcinomas of the lung, kidney, breast, and ovary (Kok et al., 1997) . The existence of recurrent losses from 3p implicates the involvement of a tumor suppressor gene(s) in this region. Thus, the identification of APPL could prove useful for investigations of these malignancies.
Materials and methods
Reagents
Restriction enzymes and other modifying enzymes were purchased from New England Biolabs or Life Technologies; the enhanced chemiluminescence Western blotting analysis system was from Amersham; anti-hemagglutinin (HA) epitope monoclonal antibody (HA.11) was from Babco; anti-Akt2, -Akt2, and -Akt3 antibodies were from Upstate Biotechnology; Grb2, Shc, p85, and p110a antibodies were from Santa Cruz Biotechnology; and pcDNA3 and pCRII TA-cloning vectors were from Invitrogen.
Yeast two-hybrid screening Two-hybrid screening was carried out essentially as described in detail elsewhere (Golemis, 1994) , using the entire human AKT2 protein as bait. Expression of the fusion bait proteins in EGY48 yeast was con®rmed by Western blot analysis using anti-AKT2 and anti-LexA polyclonal antibodies (data not shown). 
cDNA cloning
An insert cDNA fragment, designated aip1-c (representing a portion of APPL, see below), was isolated from a positive clone identi®ed by the two-hybrid screen; this fragment was used to screen a cDNA library provided by Dr G Kruh (Fox Chase Cancer Center) prepared from A2780 human ovarian cancer cells. Overlapping positive cDNA clones were isolated from the cDNA library end subjected to sequence analysis. Additional 5' sequence was obtained by the 5'-RACE method (Life Technologies) using total RNA isolated from A2780 cells. The ®nal 5'-RACE products were cloned into pCRII (Invitrogen) and sequenced.
Sequence data analysis
Homology searches for the APPL cDNA and its deduced amino acid sequences and protein stucture analyses were performed with BLAST, FASTA, University of Wisconsin GCG programs, and the tools in the ExPASy World Wide Web molecular biology server. Consensus sequences were identi®ed using the PROSITE database available on the EMBL server.
Northern blot analysis
Human multiple tissue Northern blots (Clontech) were hybridized per the supplier's instructions. As a control, ®lters were rehybridized with a GAPDH cDNA probe.
Glutathione S-transferase (GST) fusion proteins and GST pull-down assay
The aip1-c fragment and a cDNA encoding the phosphotyrosine binding (PTB) domain of APPL were each cloned into pGEX-4T-1, and E. coli BL21 was used to express GST-aip1-c or GST-APPL(PTB), respectively. The expressed GST fusion proteins were puri®ed with glutathione sepharose 4B (Pharmacia) and veri®ed by SDS ± PAGE and Coomassie brilliant blue staining. For GST pull-down assays, similar quantities of GST or GST fusion proteins immobilized on glutathione-sepharose beads were washed in 100 mM NaCl, 1 mM EDTA, 20 mM Tris-HCl (pH 8), 0.5% Nonidet P-40 and incubated with 1 mg of A2780 cell lysate, prepared as previously described , for 2 h at 48C. Bound proteins were washed with lysis buer, eluted in SDS sample buer, and subjected to SDS ± PAGE. Bound proteins were also used for in vitro protein kinase assays as well as immuno-complex protein kinase assays as described .
Polyclonal anti-aip1-c antiserum
Puri®ed GST-aip1-c protein was used to raise anti-aip1-c antiserum in rabbits. To test the spei®city of the antiserum, the cDNA encoding HA-tagged aip1-c (HA-aip1-c) was cloned into pcDNA3 and transfected into A2780 cells. Expressed proteins were analysed by immunoprecipitation followed by Western blot analysis using anti-HA antibody and anti-aip1-c antiserum, respectively, or vice versa.
FISH mapping A 1.6-kb APPL cDNA fragment (aip1) was used to screen a BAC library (Research Genetics, Inc., USA). One of the BAC clones contained the entire coding region of APPL and was used for chromosomal mapping. FISH and detection of immuno¯uorescence were performed essentially as described previously (Bell et al., 1995) . The BAC was labeled with biotin-16-dUTP by nick translation. The chromosome preparations were stained with diamidino-2-phenylindole (DAPI) and observed with a Zeiss Axiophot¯uorescence microscope. Digitized images were captured with a cooled CCD camera connected to a computer work station. Images of DAPI staning and¯uorescein signals were merged using Oncor Image software, version 1.6.
